Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011 (2011), Article ID 648217, 4 pages
http://dx.doi.org/10.1155/2011/648217
Case Report

Massive Uterine Leiomyoma in a Patient with Friedreich's Ataxia: Is There a Possible Association?

13rd Department of Surgery, University of Athens School of Medicine, Attikon University Hospital, Haidari, Athens 12462, Greece
22nd Department of Radiology, University of Athens School of Medicine, Attikon University Hospital, Haidari, Athens 12462, Greece
3University of Athens School of Medicine, Attikon University Hospital, Haidari, Athens 12462, Greece
4Department of Pediatric Surgery, University of Athens School of Medicine, Attikon University Hospital, Haidari, Athens 12462, Greece

Received 26 May 2011; Accepted 24 June 2011

Academic Editor: André Meégarbaneé

Copyright © 2011 Evangelos P. Misiakos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Friedreich, “Ueber degenerative atrophie der spinalen hinterstrange,” Virchow’s Archives of Pathology & Anatomy, vol. 26, pp. 391–419, 1863, pp. 433-459, and vol. 27, pp. 1-26, 1863. View at Publisher · View at Google Scholar
  2. L. Schöls, C. Meyer, G. Schmid, I. Wilhelms, and H. Przuntek, “Therapeutic strategies in Friedreich's ataxia,” Journal of Neural Transmission, Supplementum, no. 68, pp. 135–145, 2004. View at Google Scholar · View at Scopus
  3. M. B. Delatycki, R. Williamson, and S. M. Forrest, “Friedreich ataxia: an overview,” Journal of Medical Genetics, vol. 37, no. 1, pp. 1–8, 2000. View at Google Scholar · View at Scopus
  4. A. E. Harding, “Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering features,” Brain, vol. 104, no. 3, pp. 589–620, 1981. View at Google Scholar · View at Scopus
  5. T. De Pas, G. Martinelli, F. De Braud et al., “Friedreich's ataxia and intrathecal chemotherapy in a patient with lymphoblastic lymphoma,” Annals of Oncology, vol. 10, no. 11, p. 1393, 1999. View at Google Scholar · View at Scopus
  6. V. Campuzano, L. Montermini, M. D. Moltò et al., “Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion,” Science, vol. 271, no. 5254, pp. 1423–1427, 1996. View at Google Scholar · View at Scopus
  7. G. Isaya, H. A. O'Neill, O. Gakh, S. Park, R. Mantcheva, and S. M. Mooney, “Functional studies of frataxin,” Acta Paediatrica, International Journal of Paediatrics, Supplementum, vol. 93, no. 445, pp. 68–73, 2004. View at Google Scholar · View at Scopus
  8. A. Rötig, P. de Lonlay, D. Chretien et al., “Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia,” Nature Genetics, vol. 17, no. 2, pp. 215–217, 1997. View at Google Scholar · View at Scopus
  9. H. Puccio, D. Simon, M. Cossée et al., “Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits,” Nature Genetics, vol. 27, no. 2, pp. 181–186, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. U. Muhlenhoff, N. Richhardt, M. Ristow, G. Kispal, and R. Lill, “The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins,” Human Molecular Genetics, vol. 11, no. 17, pp. 2025–2036, 2002. View at Google Scholar · View at Scopus
  11. M. Ristow, M. F. Pfister, A. J. Yee et al., “Frataxin activates mitochondrial energy conversion and oxidative phosphorylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 22, pp. 12239–12243, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Gonzalez-Cabo, R. P. Vazquez-Manrique, M. A. Garcia-Gimeno, P. Sanz, and F. Palau, “Frataxin interacts functionally with mitochondrial electron transport chain proteins,” Human Molecular Genetics, vol. 14, no. 15, pp. 2091–2098, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Karthikeyan, L. K. Lewis, and M. A. Resnick, “The mitochondrial protein frataxin prevents nuclear damage,” Human Molecular Genetics, vol. 11, no. 11, pp. 1351–1362, 2002. View at Google Scholar · View at Scopus
  14. G. Karthikeyan, J. H. Santos, M. A. Graziewicz et al., “Reduction in frataxin causes progressive accumulation of mitochondrial damage,” Human Molecular Genetics, vol. 12, no. 24, pp. 3331–3342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Thierbach, T. J. Schulz, F. Isken et al., “Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice,” Human Molecular Genetics, vol. 14, no. 24, pp. 3857–3864, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. T. J. Schulz, R. Thierbach, A. Voigt et al., “Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth,” Journal of Biological Chemistry, vol. 281, no. 2, pp. 977–981, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Gakh, S. Park, G. Liu et al., “Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity,” Human Molecular Genetics, vol. 15, no. 3, pp. 467–479, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Guccini, D. Serio, I. Condo et al., “Fraxatin participates to the hypoxia-induced response in tumors,” Cell Death and Disease, vol. 2, Article ID e123, 2011. View at Google Scholar
  19. A. Wong, J. Yang, P. Cavadini et al., “The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis,” Human Molecular Genetics, vol. 8, no. 3, pp. 425–430, 1999. View at Google Scholar · View at Scopus
  20. S. Chamberlain and P. D. Lewis, “Studies of cellular hypersensitivity to ionising radiation in Friedreich's ataxia,” Journal of Neurology Neurosurgery and Psychiatry, vol. 45, no. 12, pp. 1136–1138, 1982. View at Google Scholar · View at Scopus
  21. J. P. Bayley, V. Launonen, and I. P. M. Tomlinson, “The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency,” BMC Medical Genetics, vol. 9, article 20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. J. Briere, J. Favier, V. El Ghouzzi et al., “Succinate dehydrogenase deficiency in human,” Cellular and Molecular Life Sciences, vol. 62, no. 19-20, pp. 2317–2324, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Barr, R. Page, and W. Taylor, “Primary small bowel ganglioneuroblastoma and Friedreich's ataxia,” Journal of the Royal Society of Medicine, vol. 79, no. 10, pp. 612–613, 1986. View at Google Scholar · View at Scopus
  24. R. Ackroyd, A. J. Shorthouse, and T. J. Stephenson, “Gastric carcinoma in siblings with Friedreich's ataxia,” European Journal of Surgical Oncology, vol. 22, no. 3, pp. 301–303, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Kidd, R. Coleman, M. Whiteford, L. H. Barron, S. A. Simpson, and N. E. Haites, “Breast cancer in two sisters with Friedreich's ataxia,” European Journal of Surgical Oncology, vol. 27, no. 5, pp. 512–514, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. P. A. Shah, I. Hassan, and A. Nafee, “Bathing trunk naevus and neurofibromatosis type 1: a unique association of Friedrich's ataxia,” Journal of the Indian Medical Association, vol. 102, no. 6, pp. 327–328, 2004. View at Google Scholar · View at Scopus
  27. H. Ahmed and Z. F. Falope, “An unusual association of a rare variant of Friedreich's ataxia with type-I neurofibromatosis in a Nigerian Fulani family: a 5-year follow-up study,” West African Journal of Medicine, vol. 18, no. 2, pp. 133–138, 1999. View at Google Scholar · View at Scopus